Laboratory Corporation of America Holdings (LabCorp) has become the first clinical reference laboratory to offer Roche COBAS AmpliPrep/COBAS TaqMan HCV Test, v2.0, a viral load assay for hepatitis C virus. Designed with enhanced ...
Health Canada has approved Roche's fully automated test, designed to assess a patient's viral load of cytomegalovirus (CMV). The COBAS AmpliPrep / COBAS TaqMan CMV assay is the first approved test, which is standardized to the WHO ...
Tags: Health Canada, CMV, clinical trial
The US Food and Drug Administration (FDA) has approved Roche's new COBAS TaqMan HIV-1 viral load test. The HIV viral load test utilizes the FDA-approved high pure system viral nucleic acid kit for manual specimen preparation and the COBAS ...
Tags: HIV-1 viral load test, COBAS TaqMan, FDA
Roche has gained FDA approval for the new HIV viral load test, the COBAS TaqMan HIV-1 Test, v2.0, and will launch the product in the US, later in 2012. The COBAS TaqMan HIV-1 Test, v2.0, targets two highly conserved regions of the HIV-1 ...
Roche has launched a new FDA-approved dual-target HIV-1 viral load test to improve the ability of physicians to monitor viral load and manage the treatment of people living with human immunodeficiency virus (HIV). The COBAS TaqMan HIV-1 ...
Tags: Viral Load Test, Dual-target HIV-1 Viral Load Test, Roche
The US Food and Drug Administration (FDA) has granted premarket approval (PMA) to Roche's new fully automated COBAS AmpliPrep / COBAS TaqMan CMV test to quantify cytomegalovirus' (CMV) DNA in human plasma specimens. The real-time ...
Tags: Roche, FDA, Viral Load Test, PCR-based CMV test